In March 2008, total turnover on the SWX Swiss Exchange, SWX Europe and Scoach Switzerland amounted to CHF 172.5 bln., which represents a decline of 12.2 % versus the previous month. For the entire first quarter of 2008, turnover stood at CHF 606.6 bln., a 1.7% increase over the previous quarter’s total of CHF 596.6 bln. CHF-denominated bond trading rose by 33.3% and in ETFs by 13.6 %. The number of trades reached a total of 12,005,813. Since the end of 2007, the blue chip SMI® index has fallen by 14.9 %, with the broadly based SPI® 13.9 % lower for the year to date. In the month of March, the SMI® declined by 4.11 % and the SPI® by 3.67 %.
Trading days: 19
Turnoverin mio. CHF |
Variation against previous month |
Variation against same month in previous year |
No. of trades |
||
Equities incl. Funds + ETSFs |
146,896 |
-13.7 % |
-34.7 % |
3,373,206 |
|
Bonds CHF |
16,608 |
-1.6 % |
15.8 % |
37,391 |
|
Exchange Traded Funds |
2,718 |
15.8 % |
-8.1 % |
18,'622 |
|
International Bonds |
788 |
-21.4 % |
-69.5 % |
8,273 |
|
Structured Products and Warrants |
5,457 |
-8.5 % |
-23.6 % |
179,062 |
|
TOTAL |
172,466 |
-12.2 % |
-31.6 % |
3,616,554 |
Monthly close |
Performance since end of previous month |
Performance year-to-date |
||
SMI® |
7,224.3 |
-4.11 % |
-14.85 % |
|
SLI Swiss Leader Index® PR |
1,105.1 |
-4.41 % |
-14.76 % |
|
SMIM® Price |
1,427.3 |
-4.36 % |
-14.62 % |
|
SPI® |
5,961.5 |
-3.67 % |
-13.92 % |
|
SPI Extra® Total Return |
1,992.7 |
-3.30 % |
-12.74 % |
|
SXI LIFE SCIENCES® Total Return |
1,672.6 |
-6.80 % |
-13.86 % |
|
SXI Bio+Medtech® Total Return |
1,775.1 |
-8.44 % |
-16.72 % |
|
SBI® Rating AAA-BBB Total Return |
99.9 |
-0.55 % |
0.36 % |
SWX Swiss Exchange AG and Scoach Switzerland Ltd. Selnaustrasse 30 Postfach CH-8021 Zürich www.swx.com / www.scoach.ch SWX Europe Limited 34th Floor One Canada Square GB-London E14 5AA www.swxeurope.com
More detailed information is available in the statistical monthly report
www.swx.com/market/statistics/monthly_data
1st quarter 2008
Trading days: 61
Turnoverin mio. CHF |
Variation against previous quarter |
Variation against same quarter in previous year |
No. of trades |
||
Equities incl. Funds + ETSFs |
526,399 |
-0.8 % |
-6.3 % |
11,200,318 |
|
Bonds CHF |
50,861 |
33.3 % |
23.4 % |
105,167 |
|
Exchange Traded Funds |
8,713 |
13.6 % |
6.5 % |
60,265 |
|
International Bonds |
2,907 |
9.3 % |
-54.9 % |
30,027 |
|
Structured Products and Warrants |
17,761 |
0.4 % |
-13.8 % |
610,036 |
|
TOTAL |
606,641 |
1.7% |
-5.0 % |
12,005,813 |
Quarterly close |
Performance since end of previous quarter |
Performanceyear-to-date |
||
SMI® |
7,224.3 |
-14.85 % |
-14.85 % |
|
SLI Swiss Leader Index® PR |
1,105.1 |
-14.76 % |
-14.76 % |
|
SMIM® Price |
1,427.3 |
-14.62 % |
-14.62 % |
|
SPI® |
5,961.5 |
-13.92 % |
-13.92 % |
|
SPI Extra® Total Return |
1,992.7 |
-12.74 % |
-12.74 % |
|
SXI LIFE SCIENCES® Total Return |
1,672.6 |
-13.86 % |
-13.86 % |
|
SXI Bio+Medtech® Total Return |
1,775.1 |
-16.72 % |
-16.72 % |
|
SBI® Rating AAA-BBB Total Return |
99.9 |
0.36 % |
0.36 % |